We are honored to welcome the esteemed members of our new Scientific Board:
- Prof. Victor Ambros, UMass Chan Medical School, Worcester, MA, USA (Nobel Laureate 2024)
- Prof. Zofia Chrzanowska-Lightowlers, Newcastle University, Newcastle, UK
- Prof. Witold Filipowicz, Friedrich Miescher Institute for Biomedical Research, Basel, Switzerland
- Prof. Ehud Gazit, Tel Aviv University, Tel Aviv, Israel
- Prof. Zdeněk Hostomský, Institute of Organic Chemistry and Biochemistry of the CAS, Prague, Czechia
- Prof. Stefan Jakobs, University Medical Center Göttingen, Germany
- Prof. Bożena Kamińska-Kaczmarek, Nencki Institute of Experimental Biology, PAS, Warsaw, Poland
- Prof. Jørgen Kjems, Aarhus University, Aarhus, Denmark
- Prof. Reinhard Lührmann, Max Planck Institute for Multidisciplinary Sciences, Göttingen, Germany
- Prof. Nikolaus Pfanner, University of Freiburg, Freiburg, Germany
- Prof. Peter Rehling, University Medical Center Göttingen, Germany
- Prof. Piotr Siciński, Dana Farber Cancer Institute, HMS, Boston, MA, USA
- Prof. Zofia Szweykowska-Kulińska, Adam Mickiewicz University, Poznan, Poland
- Prof. Grzegorz Węgrzyn, University of Gdansk, Gdansk, Poland
Each of these distinguished individuals brings invaluable expertise and insights that will undoubtedly propel our institute towards greater achievements in research and innovation.
At IMol, we are committed to fostering a collaborative environment where cutting-edge ideas and groundbreaking discoveries thrive. We look forward to the remarkable contributions our new Scientific Board members will make in advancing our mission and enhancing the impact of our work.